Editorial
|
|
|
|
|
Clinical trial acronyms under the influence of marketing departments
|
|
|
|
New Products
|
|
|
|
|
Too dangerous in atrial fibrillation
|
|
|
|
|
|
|
|
Adverse Effects
|
|
|
|
|
Reduce the dose to avoid irreversible damage
|
|
|
|
|
|
|
|
|
|
Improving the collection of reports
|
|
|
|
|
|
|
|
|
|
|
|
An interim analysis of a clinical trial
|
|
|
|
|
|
|
|
|
|
|
|
Same problem as with citalopram
|
|
|
|
|
|
|
|
|
|
Intake in excess of recommended dose
|
|
|
|
|
|
Reviews
|
|
|
|
|
Cryotherapy, salicylic acid or no treatment
|
|
|
|
|
|
|
|
|
|
In about half of migraine sufferers
|
|
|
|
|
|
|
|
|
|
Progressive rehabilitation
|
|
|
|
Outlook
|
|
|
|
|
2011 Prescrire annual report
|
|
|
|
|
|
|
|
|
|
|
|
|
|